Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 240

1.

Effectiveness and safety of anakinra in gout patients with stage 4-5 chronic kidney disease or kidney transplantation: A multicentre, retrospective study.

Loustau C, Rosine N, Forien M, Ottaviani S, Juge PA, Lioté F, Bardin T, Richette P, Dieudé P, Richez C, Bannwarth B, Schaeverbeke T, Ea HK, Truchetet ME.

Joint Bone Spine. 2018 Dec;85(6):755-760. doi: 10.1016/j.jbspin.2018.03.015. Epub 2018 Apr 11.

PMID:
29654950
2.

Switching from originator infliximab to biosimilar CT-P13 in real-life: The weight of patient acceptance.

Scherlinger M, Germain V, Labadie C, Barnetche T, Truchetet ME, Bannwarth B, Mehsen-Cetre N, Richez C, Schaeverbeke T; FHU ACRONIM.

Joint Bone Spine. 2018 Oct;85(5):561-567. doi: 10.1016/j.jbspin.2017.10.003. Epub 2017 Nov 14.

PMID:
29154920
3.

Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study.

Kostine M, Rouxel L, Barnetche T, Veillon R, Martin F, Dutriaux C, Dousset L, Pham-Ledard A, Prey S, Beylot-Barry M, Daste A, Gross-Goupil M, Lallier J, Ravaud A, Forcade E, Bannwarth B, Truchetet ME, Richez C, Mehsen N, Schaeverbeke T; FHU ACRONIM.

Ann Rheum Dis. 2018 Mar;77(3):393-398. doi: 10.1136/annrheumdis-2017-212257. Epub 2017 Nov 16.

PMID:
29146737
4.

Efficacy of baricitinib in the treatment of rheumatoid arthritis.

Richez C, Truchetet ME, Kostine M, Schaeverbeke T, Bannwarth B.

Expert Opin Pharmacother. 2017 Sep;18(13):1399-1407. doi: 10.1080/14656566.2017.1359256. Epub 2017 Jul 27. Review.

PMID:
28737053
5.

Nerve Growth Factor Antagonists: Is the Future of Monoclonal Antibodies Becoming Clearer?

Bannwarth B, Kostine M.

Drugs. 2017 Sep;77(13):1377-1387. doi: 10.1007/s40265-017-0781-6. Review.

PMID:
28660479
6.
7.

Denosumab-induced severe hypocalcemia in a patient with Paget's disease of bone and impaired renal function.

Kostine M, Mehsen-Cetre N, Bannwarth B.

Therapie. 2017 Jun;72(3):383-385. doi: 10.1016/j.therap.2016.07.003. Epub 2016 Sep 15. No abstract available.

PMID:
27745697
8.

Comment on: Intravenous neridronate in the treatment of acute painful knee osteoarthritis: a randomized controlled study.

Bannwarth B, Barnetche T.

Rheumatology (Oxford). 2015 Nov;54(11):2116-7. doi: 10.1093/rheumatology/kev292. Epub 2015 Sep 2. No abstract available.

PMID:
26338665
9.

Immunogenicity of biologic agents in rheumatoid arthritis patients: lessons for clinical practice.

Schaeverbeke T, Truchetet ME, Kostine M, Barnetche T, Bannwarth B, Richez C.

Rheumatology (Oxford). 2016 Feb;55(2):210-20. doi: 10.1093/rheumatology/kev277. Epub 2015 Aug 12. Review.

PMID:
26268816
10.

Biologics in the treatment of chronic pain: a new era of therapy?

Bannwarth B, Kostine M.

Clin Pharmacol Ther. 2015 Feb;97(2):122-4. doi: 10.1002/cpt.20. Epub 2014 Dec 15.

PMID:
25670514
11.

Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry.

Truchetet ME, Poursac N, Barnetche T, Shipley E, Gottenberg JE, Bannwarth B, Richez C, Schaeverbeke T.

Arthritis Res Ther. 2016 Mar 30;18:72. doi: 10.1186/s13075-016-0956-7.

12.

Atacicept as an investigated therapy for rheumatoid arthritis.

Richez C, Truchetet ME, Schaeverbeke T, Bannwarth B.

Expert Opin Investig Drugs. 2014 Sep;23(9):1285-94. doi: 10.1517/13543784.2014.943835. Epub 2014 Jul 31. Review.

PMID:
25078871
13.

[Bone fragility].

Poursac N, Mehsen-Cêtre N, Bannwarth B.

Rev Prat. 2014 Mar;64(3):425-32. Review. French. No abstract available.

PMID:
24851381
14.

Targeting nerve growth factor (NGF) for pain management: what does the future hold for NGF antagonists?

Bannwarth B, Kostine M.

Drugs. 2014 Apr;74(6):619-26. doi: 10.1007/s40265-014-0208-6.

PMID:
24691709
15.

Are there concerns about generic medicines in rheumatology?

Bannwarth B, Kostine M, Poursac N.

Joint Bone Spine. 2014 Jan;81(1):1-3. doi: 10.1016/j.jbspin.2013.10.001. Epub 2013 Nov 20. No abstract available.

PMID:
24268925
16.

A pharmacokinetic and clinical assessment of tofacitinib for the treatment of rheumatoid arthritis.

Bannwarth B, Kostine M, Poursac N.

Expert Opin Drug Metab Toxicol. 2013 Jun;9(6):753-61. doi: 10.1517/17425255.2013.789500. Epub 2013 Apr 9. Review.

PMID:
23570265
17.

Licensing of antirheumatic drugs: are the EMA and FDA on the same page?

Bannwarth B, Berdaï D, Kostine M.

Joint Bone Spine. 2013 Mar;80(2):121-3. doi: 10.1016/j.jbspin.2012.09.024. Epub 2012 Nov 7. No abstract available.

PMID:
23141714
18.

Will abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose?

Bannwarth B.

Drugs. 2012 Sep 10;72(13):1713-23. doi: 10.2165/11635860-000000000-00000. Review.

PMID:
22931520
19.

[Pharmacological management of inflammatory rheumatic conditions].

Bannwarth B.

Therapie. 2011 Sep-Oct;66(5):377-81. doi: 10.2515/therapie/2011055. Epub 2011 Oct 27. Review. French.

PMID:
22031680
20.

Nonspecific low back pain: assessment of available medications.

Bannwarth B, Kostine M, Shipley E.

Joint Bone Spine. 2012 Mar;79(2):134-6. doi: 10.1016/j.jbspin.2011.06.008. Epub 2011 Sep 25. Review.

PMID:
21944881
21.

Clinical safety of tocilizumab in rheumatoid arthritis.

Bannwarth B, Richez C.

Expert Opin Drug Saf. 2011 Jan;10(1):123-31. doi: 10.1517/14740338.2011.537256. Epub 2010 Dec 2. Review.

PMID:
21121872
22.

Irrelevance of the WHO analgesic ladder for managing rheumatic pain.

Bannwarth B.

Joint Bone Spine. 2010 Jan;77(1):1-3. doi: 10.1016/j.jbspin.2009.11.001. Epub 2009 Dec 22. No abstract available.

PMID:
20022786
23.

The dextropropoxyphene controversy.

Bannwarth B, Richez C.

Joint Bone Spine. 2009 Oct;76(5):449-51. doi: 10.1016/j.jbspin.2009.04.004. Epub 2009 Jul 14. No abstract available.

PMID:
19604717
24.

Prevalence of fibromyalgia: a survey in five European countries.

Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, Saraiva F, Nacci F, Thomas E, Caubère JP, Le Lay K, Taieb C, Matucci-Cerinic M.

Semin Arthritis Rheum. 2010 Jun;39(6):448-53. doi: 10.1016/j.semarthrit.2008.12.003. Epub 2009 Feb 27.

PMID:
19250656
25.

Is there a role for anticonvulsants in the management of rheumatic pain?

Bannwarth B.

Joint Bone Spine. 2008 Dec;75(6):633-5. doi: 10.1016/j.jbspin.2008.06.005. Epub 2008 Sep 27. No abstract available.

PMID:
18824385
26.

Fibromyalgia syndrome in the general population of France: a prevalence study.

Bannwarth B, Blotman F, Roué-Le Lay K, Caubère JP, André E, Taïeb C.

Joint Bone Spine. 2009 Mar;76(2):184-7. doi: 10.1016/j.jbspin.2008.06.002. Epub 2008 Sep 25.

PMID:
18819831
27.
28.

[Prescription of aspirin in recent acute painful disorders: results of a survey among French general practitioners].

Bannwarth B, Allaert FA, Dubreuil C, Allain H, Azerad J, Becq JP, Trèves R, Valade D.

Therapie. 2007 Nov-Dec;62(6):477-81. doi: 10.2515/therapie:2007075. Epub 2008 Mar 4. French.

PMID:
18316013
29.

[Admissions of elderly to French emergency departments related to adverse drug events].

Trinh-Duc A, Doucet J, Bannwarth B, Trombert-Paviot B, Carpentier F, Bouget J, Queneau P; Association Pédagogique Nationale pour l'Enseignement de la Thérapeutique (APNET).

Therapie. 2007 Sep-Oct;62(5):437-41. doi: 10.2515/therapie:2007063. Epub 2008 Jan 19. French.

PMID:
18206105
30.

Admissions des sujets âgés aux Services d'Accueil des Urgences pour effets indésirables médicamenteux.

Trinh-Duc A, Doucet J, Bannwarth B, Trombert-Paviot B, Carpentier F, Bouget J, Queneau P.

Therapie. 2007 Sep-Oct;62(5):437-41. doi: 10.2515/therapie:2007063. French.

PMID:
27393632
31.

Lumiracoxib in the management of osteoarthritis and acute pain.

Bannwarth B, Bérenbaum F.

Expert Opin Pharmacother. 2007 Jul;8(10):1551-64. Review.

PMID:
17661736
32.

Transdermal fentanyl in patients with osteoarthritis: comment on the article by Langford et al.

Bannwarth B.

Arthritis Rheum. 2007 Feb;56(2):697-8. No abstract available.

33.

Emergency department visits caused by adverse drug events: results of a French survey.

Queneau P, Bannwarth B, Carpentier F, Guliana JM, Bouget J, Trombert B, Leverve X, Lapostolle F, Borron SW, Adnet F; Association Pédagogique Nationale pour l'Enseignement de la Thérapeutique (APNET).

Drug Saf. 2007;30(1):81-8.

PMID:
17194173
34.

Drug-induced musculoskeletal disorders.

Bannwarth B.

Drug Saf. 2007;30(1):27-46. Review.

PMID:
17194169
35.

Peptic ulcer disease in a patient with ankylosing spondylitis receiving a conventional nonsteroidal anti-inflammatory drug.

Bannwarth B, Zerbib F.

Nat Clin Pract Rheumatol. 2006 Feb;2(2):107-11;quiz 112.

PMID:
16932664
36.

Guidelines for the use of antidepressants in painful rheumatic conditions.

Perrot S, Maheu E, Javier RM, Eschalier A, Coutaux A, LeBars M, Bertin P, Bannwarth B, Trèves R.

Eur J Pain. 2006 Apr;10(3):185-92. Epub 2005 Apr 18. Review.

PMID:
16490727
37.

Acetaminophen or NSAIDs for the treatment of osteoarthritis.

Bannwarth B.

Best Pract Res Clin Rheumatol. 2006 Feb;20(1):117-29. Review.

PMID:
16483911
38.

Molecular lipophilicity determination of a huperzine series by HPLC: comparison of C18 and IAM stationary phases.

Darrouzain F, Dallet P, Dubost JP, Ismaili L, Pehourcq F, Bannwarth B, Matoga M, Guillaume YC.

J Pharm Biomed Anal. 2006 Apr 11;41(1):228-32. Epub 2006 Jan 6.

PMID:
16406443
39.

COX-2 selective drugs and cardiovascular risks: same data but discrepant conclusions?

Bannwarth B.

Expert Opin Drug Saf. 2006 Jan;5(1):1-2; author reply 1-2. No abstract available.

PMID:
16370948
40.

Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: how strong is the evidence?

Bannwarth BG.

BMJ. 2005 Dec 17;331(7530):1474. No abstract available.

41.

Antidepressants in rheumatic disorders: do they act as analgesics or antidepressants?

Bannwarth B.

Joint Bone Spine. 2005 Oct;72(5):351-3. Epub 2004 Nov 11. No abstract available.

PMID:
16214066
42.

Measuring the contribution of pharmacological treatment to advice to stay active in patients with subacute low-back pain: a randomised controlled trial.

Rossignol M, Allaert FA, Rozenberg S, Valat JP, Avouac B, Peres G, Le Teuff G, Bannwarth B.

Pharmacoepidemiol Drug Saf. 2005 Dec;14(12):861-7.

PMID:
15991263
43.

[Adverse drug effects: a prospective study by Apnet performed in seven emergency care units in France: propositions for preventive measures].

Queneau P, Trombert B, Carpentier F, Trinh-Duc A, Bannwarth B, Bouget J; Association pédagogique nationale pour l'enseignment de la thérapeutique.

Ann Pharm Fr. 2005 Mar;63(2):131-42. French.

PMID:
15976680
44.

A randomized, double-blind, placebo controlled triphosphate in study of oral adenosine subacute low back pain.

Bannwarth B, Allaert FA, Avouac B, Rossignol M, Rozenberg S, Valat JP.

J Rheumatol. 2005 Jun;32(6):1114-7.

PMID:
15940776
45.

[Bone mineral density and bone metabolism in spondylarthropathies].

Malterre L, Schaeverbeke T, Lequen L, Chène G, Bannwarth B, Dehais J.

Rev Med Interne. 2005 May;26(5):381-5. Epub 2005 Mar 17. French.

PMID:
15893028
46.

Clinical pharmacology of lumiracoxib, a second-generation cyclooxygenase 2 selective inhibitor.

Bannwarth B, Berenbaum F.

Expert Opin Investig Drugs. 2005 Apr;14(4):521-33. Review.

PMID:
15882125
47.

Do selective cyclo-oxygenase-2 inhibitors have a future?

Bannwarth B.

Drug Saf. 2005;28(3):183-9.

PMID:
15733024
48.

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, Hauselmann HJ, Herrero-Beaumont G, Jordan K, Kaklamanis P, Leeb B, Lequesne M, Lohmander S, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Swoboda B, Varatojo R, Verbruggen G, Zimmermann-Gorska I, Dougados M; EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Ann Rheum Dis. 2005 May;64(5):669-81. Epub 2004 Oct 7. Review.

49.

[Prescribing patterns of rofecoxib in the primary care setting: results of a French survey].

Bannwarth B, Logeart I, Vergult G.

Rev Med Interne. 2004 Oct;25(10):710-4. French.

PMID:
15471596
50.

Supplemental Content

Loading ...
Support Center